Cargando…

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes

Detalles Bibliográficos
Autores principales:	Kishi, Hiroyuki, Hamana, Hiroshi, Shitaoka, Kiyomi, Muraguchi, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645188/ http://dx.doi.org/10.1186/2051-1426-3-S2-P74

Ejemplares similares

NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
por: Mojic, Marija, et al.
Publicado: (2021)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Comprehensive and efficient analyses of T cell receptors for cancer antigens in peptide-vaccinated patients using a single cell-based gene cloning system
por: Nakagawa, Hidetoshi, et al.
Publicado: (2014)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

Evaluation of chimeric antigen receptor of humanized rabbit‐derived T cell receptor‐like antibody
por: Nakamura, Tomoko, et al.
Publicado: (2022)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
por: Bedri, Shahinaz, et al.
Publicado: (2014)

Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
por: Poschke, Isabel, et al.
Publicado: (2015)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma
por: Hall, MacLean, et al.
Publicado: (2015)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
por: Chen, Wan-Yu, et al.
Publicado: (2014)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2013)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Immediate triggering of 4-1BB co-stimulation during initiation of tumor-infiltrating lymphocyte (TIL) expansion from melanoma tumors accelerates CD8+ T-cell outgrowth and tumor specificity
por: Chacon, Jessica, et al.
Publicado: (2013)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
por: Nguyen, Linh T, et al.
Publicado: (2013)

Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

Anti-tumor characteristics of radiation-induced tumor-infiltrating neutrophils
por: Takeshima, Tsuguhide, et al.
Publicado: (2014)

Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers
por: Thi Viet Ha, My, et al.
Publicado: (2023)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Characterization of tumor infiltrated cells in mouse model
por: Liou, Yae-Huei, et al.
Publicado: (2015)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Validation and clinical correlation of triplex CD3, CD8 and FOXP3 IHC of tumor-infiltrating lymphocytes in follicular lymphoma
por: Mansfield, James, et al.
Publicado: (2014)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

Clonally Expanded Decidual Effector Regulatory T Cells Increase in Late Gestation of Normal Pregnancy, but Not in Preeclampsia, in Humans
por: Tsuda, Sayaka, et al.
Publicado: (2018)

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer
por: Sukumar, Madhusudhanan, et al.
Publicado: (2015)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Targeting YAP-dependent MDSC infiltration impairs tumor progression
por: Wang, Guocan, et al.
Publicado: (2015)

The role of transcription factor Runx2 in tumor infiltrating T cells
por: Mbofung, Rina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0pu9kjievda7a9thisu6gn4ghd